Income statement
USD
Annual
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Revenue | 97M | 44M | 38M | 15M | 12M |
| Gross Profit | 13M | -2M | 12M | 4M | 4M |
| Operating Income | -21M | -18M | 3M | -1M | 140K |
| EBITDA | -13M | -26M | 5M | -1M | 274K |
| Net Income | -19M | -25M | 2M | -2M | 77K |
| EPS (Diluted) | — | — | — | — | — |
Industrials
Live Price
Offline$0.00004
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 245 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Xebec Adsorption Inc. (XEBEQ) is a Industrials stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of +119.0%, EPS growth of +53.8%, a dividend yield of 0.0%. What stands out right now is revenue +119.0%, EPS +53.8%, free cash flow -138.2% with operating margin 0.0% and ROIC 0.0%. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines XEBEQ price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Industrials peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
XEBEQ
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
XEBEQ Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for XEBEQ and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$11.8M
-20.5% YoY
FY Net Income
$77.2K
+103.6% YoY
Free Cash Flow
-$1.7M
+26.4% YoY
Revenue Growth
+119.0%
EPS Growth
+53.8%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Revenue | 97M | 44M | 38M | 15M | 12M |
| Gross Profit | 13M | -2M | 12M | 4M | 4M |
| Operating Income | -21M | -18M | 3M | -1M | 140K |
| EBITDA | -13M | -26M | 5M | -1M | 274K |
| Net Income | -19M | -25M | 2M | -2M | 77K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Cash & Equivalents | 40M | 132M | 17M | 3M | 1M |
| Total Assets | 393M | 355M | 51M | 11M | 7M |
| Total Liabilities | 144M | 91M | 21M | 12M | 10M |
| Shareholder Equity | 249M | 265M | 30M | -454K | -4M |
| Total Debt | 70M | 48M | 8M | 6M | 7M |
| Net Debt | 48M | -84M | -9M | 3M | 6M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
1M
+31.6% YoY
Capital Expenditures
267K
-27.5% YoY
Free Cash Flow
2M
+26.4% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
0.0%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.